Mehta Rajat: insider trades.
Mehta Rajat reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Mehta Rajat
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | Officer · EVP, GBL Commercial Operations | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-05 | Bio-Rad Laboratories, Inc. | M | 456 | $0 | 599 | Form 4 |
| 2026-09-05 | Bio-Rad Laboratories, Inc. | F | 233 | $386.11 | 366 | Form 4 |
| 2026-09-05 | Bio-Rad Laboratories, Inc. | M | 1,370 | $0 | 1,736 | Form 4 |
| 2026-09-05 | Bio-Rad Laboratories, Inc. | F | 504 | $386.11 | 1,232 | Form 4 |
Questions
What stock did Mehta Rajat buy or sell?
Mehta Rajat reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Mehta Rajat the same person as other filers with this name?
This page covers SEC CIK 2081681 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mehta-rajat-2081681.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.